Highbridge Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Highbridge Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-181,906	Closed	-$1.64M	–	1717
2017 Q1	$1.64M	Buy	181,906 +159,897	+727%	+$1.67M	0.02%	489
2016 Q4	$238K	Sell	22,009 -43,406	-66%	-$579K	﹤0.01%	1056
2016 Q3	$1.07M	Sell	65,415 -77,686	-54%	-$1.09M	0.02%	549
2016 Q2	$1.36M	Buy	143,101 +120,177	+524%	+$1.31M	0.02%	530
2016 Q1	$322K	Sell	22,924 -5,419	-19%	-$56.1K	0.01%	1156
2015 Q4	$308K	Buy	+28,343	New	+$256K	﹤0.01%	1178
2015 Q3	–	Sell	-66,447	Closed	-$607K	–	1898
2015 Q2	$607K	Sell	66,447 -11,946	-15%	-$90.6K	0.01%	882
2015 Q1	$529K	Buy	+78,393	New	+$315K	0.01%	948

Other funds holding NPTN

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

QAM

Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Highbridge Capital Management's NPTN Position: Q2 2017 in Review

Highbridge Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2017, closing a stake of 181,906 shares — an estimated $1.64M sold.

Highbridge Capital Management first reported a position in NPTN in Q1 2015 and held it in 8 quarters. The position peaked at $1.64M in Q1 2017. 101 funds tracked by Wall St. Rank hold NPTN as of Q2 2017.

Highbridge Capital Management reported no remaining NEOPHOTONICS CORP position as of Q2 2017 after selling out during the quarter.
Highbridge Capital Management sold 181,906 NEOPHOTONICS CORP shares in Q2 2017, an estimated $1.64M.
Highbridge Capital Management first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 8 quarters.
Highbridge Capital Management's NEOPHOTONICS CORP position peaked at $1.64M in Q1 2017.
101 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.